Suppr超能文献

伊朗患者中幽门螺杆菌感染与多发性硬化症的关系。

Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.

作者信息

Mohebi Nafiseh, Mamarabadi Mansoureh, Moghaddasi Mehdi

机构信息

Department of Neurology, Rasool-e-Akram Hospital, Tehran University of Medical Sciences , Tehran, Iran.

出版信息

Neurol Int. 2013 Jun 25;5(2):31-3. doi: 10.4081/ni.2013.e10.

Abstract

Multiple sclerosis (MS) is the most prevalent central nervous system demyelinating disease. There are known risk factors for MS. However, there is uncertainty in its protective factors. Few studies have demonstrated that some chronic infections may have protective effects on this disease. We carried this study to investigate the relation between Helicobacter pylori (HP) infection and the prevalence and severity of MS. In this case-control study, 163 MS patients and 150 sex- and age- matched controls were included. Blood samples for IgG and IgM anti HP antibodies were collected from all individuals. Also, the Expanded Disability Status Scale (EDSS) was used to evaluate the MS patients. Suitable statistical analysis was applied. A Significant difference was observed in seropositivity between these two groups (P<0.001) but no significant difference was seen in seropositivity between conventional and opticospinal MS (P=0.522). No significant difference was observed in seropositivity among ages (P=0.075) and between genders (P=0.204). A significant difference was seen in EDSS value between seropositive and seronegative patients (P=0.017). We concluded that patients with HP infection had lower incidence of multiple sclerosis and MS patients with HP infection showed lower neurologic complications, which can demonstrate that HP infection may have a protective influence on MS pathogenesis.

摘要

多发性硬化症(MS)是最常见的中枢神经系统脱髓鞘疾病。MS存在已知的危险因素。然而,其保护因素尚不确定。很少有研究表明某些慢性感染可能对该疾病具有保护作用。我们开展这项研究以调查幽门螺杆菌(HP)感染与MS患病率及严重程度之间的关系。在这项病例对照研究中,纳入了163例MS患者和150例性别及年龄匹配的对照。采集了所有个体的抗HP抗体IgG和IgM血样。此外,使用扩展残疾状态量表(EDSS)对MS患者进行评估。应用了合适的统计分析。两组之间的血清阳性率存在显著差异(P<0.001),但传统型和视神经脊髓型MS之间的血清阳性率无显著差异(P=0.522)。各年龄组之间(P=0.075)以及不同性别之间(P=0.204)的血清阳性率均无显著差异。血清阳性和血清阴性患者的EDSS值存在显著差异(P=0.017)。我们得出结论,HP感染患者的多发性硬化症发病率较低,且HP感染的MS患者神经并发症较少,这表明HP感染可能对MS发病机制具有保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6eb/3718244/c53b8d157ba3/ni-2013-2-e10-g001.jpg

相似文献

1
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
Neurol Int. 2013 Jun 25;5(2):31-3. doi: 10.4081/ni.2013.e10.
2
The protective effect of Helicobacter Pylori infection on the susceptibility of multiple sclerosis.
J Neuroimmunol. 2019 Dec 15;337:577069. doi: 10.1016/j.jneuroim.2019.577069. Epub 2019 Sep 14.
3
Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
Curr J Neurol. 2020 Apr 3;19(2):59-66. doi: 10.18502/cjn.v19i2.4942.
4
Relevance of infection in Egyptian multiple sclerosis patients.
Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):41. doi: 10.1186/s41983-018-0043-x. Epub 2018 Dec 7.
5
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):603-7. doi: 10.1136/jnnp-2014-309495. Epub 2015 Jan 19.
6
Association between Helicobacter pylori infection and arterial stiffness: Results from a large cross-sectional study.
PLoS One. 2019 Aug 29;14(8):e0221643. doi: 10.1371/journal.pone.0221643. eCollection 2019.
8
Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population.
J Neuroimmunol. 2007 Mar;184(1-2):227-31. doi: 10.1016/j.jneuroim.2006.12.010. Epub 2007 Feb 12.
9
Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
Acta Neurol Scand. 2016 Apr;133(4):268-75. doi: 10.1111/ane.12453. Epub 2015 Jun 16.
10
Helicobacter pylori infection and demyelinating disease of the central nervous system.
J Neuroimmunol. 2019 Apr 15;329:14-19. doi: 10.1016/j.jneuroim.2018.06.017. Epub 2018 Jun 30.

引用本文的文献

1
Association of infection with the risk of neurodegenerative disorders: a systematic review and meta-analysis.
Front Med (Lausanne). 2025 Jul 4;12:1573299. doi: 10.3389/fmed.2025.1573299. eCollection 2025.
2
The Probable Infectious Origin of Multiple Sclerosis.
NeuroSci. 2023 Sep 7;4(3):211-234. doi: 10.3390/neurosci4030019. eCollection 2023 Sep.
3
Helicobacter pylori infection and risk of multiple sclerosis: an updated meta-analysis.
Neurol Sci. 2024 Jun;45(6):2539-2548. doi: 10.1007/s10072-024-07328-8. Epub 2024 Jan 20.
4
Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
Curr J Neurol. 2020 Apr 3;19(2):59-66. doi: 10.18502/cjn.v19i2.4942.
5
The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.
Mult Scler J Exp Transl Clin. 2023 Sep 25;9(3):20552173231196992. doi: 10.1177/20552173231196992. eCollection 2023 Jul-Sep.
7
COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.
Med Clin (Engl Ed). 2023 Mar 10;160(5):187-192. doi: 10.1016/j.medcle.2022.06.021. Epub 2023 Mar 3.
8
COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.
Med Clin (Barc). 2023 Mar 10;160(5):187-192. doi: 10.1016/j.medcli.2022.06.020. Epub 2022 Aug 10.
9
Infection and Extragastric Diseases-A Focus on the Central Nervous System.
Cells. 2021 Aug 25;10(9):2191. doi: 10.3390/cells10092191.
10

本文引用的文献

1
Multiple sclerosis and seizures: possible role of Helicobacter pylori.
Eur J Neurol. 2011 Sep;18(9):e116; author reply e117. doi: 10.1111/j.1468-1331.2011.03454.x.
2
JC virus-induced Progressive Multifocal Leukoencephalopathy.
Future Virol. 2010 May;5(3):313-323. doi: 10.2217/fvl.10.12.
3
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Brain. 2010 Jul;133(Pt 7):1914-29. doi: 10.1093/brain/awq118. Epub 2010 Jun 9.
5
Helicobacter Pylori associated global gastric cancer burden.
Front Biosci (Landmark Ed). 2009 Jan 1;14(4):1490-504. doi: 10.2741/3320.
7
Multiple sclerosis.
Lancet. 2008 Oct 25;372(9648):1502-17. doi: 10.1016/S0140-6736(08)61620-7.
8
Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis.
Med Hypotheses. 2008;70(6):1223. doi: 10.1016/j.mehy.2007.12.008. Epub 2008 Jan 31.
9
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.
Ann Neurol. 2007 Jun;61(6):504-13. doi: 10.1002/ana.21141.
10
Environmental risk factors for multiple sclerosis. Part I: the role of infection.
Ann Neurol. 2007 Apr;61(4):288-99. doi: 10.1002/ana.21117.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验